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Introduction {#sec1}
============

In Gram-negative bacteria, the outer membrane (OM) serves as a highly selective permeability barrier, protecting bacterial cells from a hostile external environment, while allowing import of the nutrients required for survival and growth ([@bib28]). In addition, the OM forms the interface between the bacteria and its external environment. As such, it plays a pivotal role in the adherence of bacteria to surfaces, as well as in attack and defense ([@bib13], [@bib21]). To perform this diverse set of functions, the OM contains a multitude of integral membrane proteins ([@bib23]). The transport of these proteins from their site of synthesis in the cytoplasm, and their correct and efficient insertion into the OM, poses a significant challenge. Gram-negative bacteria possess a specialized nano-machine termed the β barrel assembly machinery (BAM complex) charged with this task ([@bib20], [@bib35]). In addition, these bacteria possesses the translocation and assembly module (the TAM), a nano-machine which is important in the proper assembly of a subset of OM proteins ([@bib12], [@bib24], [@bib32]). In the Gram-negative bacterium *Escherichia coli*, the BAM complex contains five (BamA-E) components centered around BamA, an integral OM protein of the Omp85 family ([@bib3], [@bib10], [@bib11]). The TAM is composed of two subunits, TamA an Omp85 family protein evolutionarily related to BamA and the enigmatic inner membrane-anchored protein TamB ([@bib12]). In *E. coli* and many other Gram-negative bacteria, the presence of BamA is essential for the growth and survival of the cell ([@bib34], [@bib37]). The TAM on the other hand is dispensable for growth of *E. coli* under lab conditions; however, in a mouse model of infection, TAM mutants from various pathogens exhibit attenuated virulence ([@bib24]).

In *E. coli,* TamA and TamB have been shown to associate and, as TamB is embedded in the inner membrane via a signal anchor, it must span the periplasm to interact with TamA ([@bib24]). In keeping with this, analysis of recombinant TamB by atomic force microscopy and dynamic light scattering shows it to be highly prolate, with a length of 150--200 Å ([@bib27]). Interaction between TamA and TamB occurs via the conserved C-terminal DUF490 domain of TamB and POTRA1 of TamA and is required for the proper functioning of the TAM *in vitro* ([@bib25], [@bib27]). *In vivo*, the presence of both TamA and TamB is required for the correct assembly of a number of OM proteins ([@bib13], [@bib24], [@bib32]). In keeping with the role of the TAM in infection, these proteins are predominantly virulence factors, with prominent roles in bacterial adhesion and biofilm formation ([@bib12], [@bib24], [@bib32]). Intriguingly, recent reports have shown that TamB homologs exist even in bacteria that lack TamA ([@bib33], [@bib38]). In *Borrelia burgdorferi*, the causative agent of Lyme disease, TamB has been shown to interact with BamA and appears to be essential for viability ([@bib15]). While further investigation is required, these data point toward a more general role for TamB homologs in OM protein biogenesis.

TamB is a large protein by bacterial standards, consisting in *E. coli* of 1,259 amino acids, which are predicted to be composed of predominantly β strand structure ([Figure 1](#fig1){ref-type="fig"}A) ([@bib12], [@bib27]). To date, no high-resolution structural information on TamB is available and, as no homologs have been structurally characterized, very little information about its structure can be inferred. In this work, we report the crystal structure of TamB~963-1138~ from *E. coli*, a region spanning half of the conserved DUF490 domain ([Figure 1](#fig1){ref-type="fig"}B). This structure reveals that TamB~963-1138~ forms a previously undescribed fold, consisting of a concave β sheet with a highly hydrophobic interior, which we refer to as a β taco. We show that TamB~963-1138~ is stabilized by detergent molecules, which likely reside in the hydrophobic cavity of the β taco. Furthermore, sequence analysis of TamB suggests that this structure is shared by the majority of the molecule. Given the role of TamB in the transport and assembly of integral membrane proteins we postulate this hydrophobic cavity may serve as a chaperone and conduit for the hydrophobic β strands of target proteins. This proposed mechanism of TamB has striking similarities to the lipopolysaccharide (LPS) transport system Lpt in which a membrane spanning β jelly roll with a hydrophobic groove is predicted to act as a conduit for LPS ([@bib4]).Figure 1Schematic and Secondary Structure of TamB~963-1138~(A) Schematic of TamB showing domains, structural elements, and secondary structure.(B) Sequence and secondary structure of TamB~963-1138,~ secondary structure from crystal structure is shown: blue arrows represent β sheets; broken red lines represent residues not resolved in the crystal structure. Residues discussed in text are colored red, and those subjected to mutagenesis are colored green.

Results and Discussion {#sec2}
======================

The Crystal Structure of TamB~963-1138~ {#sec2.1}
---------------------------------------

To gain insight into the structure of the DUF490 domain of TamB, we attempted to crystalize the full-length domain, as well as a number of truncation constructs. One of these constructs, consisting of residues 963--1,138 of TamB (designated TamB~963-1138~) produced diffraction quality crystals and data was collected and anisotropically processed to 1.86--2.2 Å ([@bib16], [@bib31]). As no homologs of TamB have been structurally characterized, selenomethionine-labeled protein was prepared, crystalized, and the structure was solved using single-wavelength anomalous dispersion (SAD) ([Table 1](#tbl1){ref-type="table"}). Substructure solution proved difficult because only weak anomalous signal was present in the data. Despite this, a heavy atom substructure was determined consisting of one high-occupancy site, as well as two low-occupancy sites in close proximity ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Initial SAD phases lacked contrast, making hand determination impossible. However, density modification greatly improved contrast, allowing main-chain tracing ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). This initial model was then used to phase the higher-resolution native data by molecular replacement, and the structure was built and refined ([Table S1](#mmc1){ref-type="supplementary-material"}). The crystal structure of TamB~963-1138~ revealed an elongated taco-shaped molecule consisting entirely of β sheet and random coil. This β taco structure is formed by two molecules of TamB~963-1138~, which interact via their N-terminal β strand to form a continuous 16-stranded curved β structure ([Figure 2](#fig2){ref-type="fig"}A). The two molecules of TamB~963-1138~ in this structure consist of eight β strands related by non-crystallographic symmetry. The first of these strands runs parallel to the second, with the subsequent strands adopting an anti-parallel structure ([Figure 2](#fig2){ref-type="fig"}B). Between the first and second β strands 29 residues lack electron density due to disorder. This disordered section leads to ambiguity regarding which molecule the first TamB~963-1138~ β strand originates from. Either this first β strand is connected by the disordered loop to the parallel strand of one monomer creating a continuous eight-stranded sheet ([Figure 2](#fig2){ref-type="fig"}C), or this loop connects β strand 1 to β strand 2 of the opposing molecule, leading to a β zipper intercalation of the two molecules ([Figure 2](#fig2){ref-type="fig"}D). Analysis of purified TamB~963-1138~ in solution by size-exclusion chromatography coupled to multi-angle laser light scatter (SEC-MALS) gave a molecular mass of 38 kDa for TamB~963-1138.~ This is twice the 19 kDa mass of an individual TamB~963-1138~ molecule, showing that the crystallography dimer is also the solution state of TamB~963-1138~ ([Figure S2](#mmc1){ref-type="supplementary-material"}A).Figure 2The Crystal Structure of TamB~963-1138~(A) Cross-eye stereo view of the TamB~963-1138~ dimer; molecule A is colored blue and molecule B is colored yellow.(B) Jones\'s Rainbow of TamB~963-1138~, colored from blue (N terminus) to red (C terminus).(C) TamB~963-1138~ showing disordered region connectivity option one between Asp~995~ and Pro~1025~ of molecule A.(D) TamB~963-1138~ showing connectivity option two between Asp~995~ of molecule A and Ile~1026~ of molecule B.(E) The kink at the base of the TamB~963-1138~ β taco is created by Pro~987~ and Pro~1071~ and Gly~1035~.(F) A large conformational difference is observed in the loop between β strands 6 and 7 of TamB~963-1138~ molecule A and B.Table 1TamB~963-1138~ Crystallographic Data Collection and Refinement StatisticsDUF490(963--1,138) SelMetDUF490(963--1,138) Native**Data Collection**[a](#tblfn1){ref-type="table-fn"}Space group*P3*~*2*~*21P3*~*2*~*21*Cell dimensions a, b, c (Å)57.2,57.2, 220.9157.24, 57.24, 220.71 α, β, γ (°)90, 90, 12090, 90, 120Wavelength0.97630.9763Resolution (Å)73.58--2.69 (2.82--2.69)49.57--1.86 (1.89--1.86)R~merge~4.2 (64.5)8.3 (288.7)R~pim~1.1 (19.3)4.1 (174.0)*I/*σ(*I*)46.8 (3.2)11.3 (0.6)Completeness (%)99.0 (94.8)94.5 (99.2)Redundancy17.8 (12.8)9.2 (6.8)No. of reflections35,019 (2,208)**Refinement Statistics**Anisotropy correction[b](#tblfn2){ref-type="table-fn"}Resolution truncationa^∗^, b^∗^, c^∗^ (Å)2.2, 2.2, 1.86Reflections discardedOriginal, discarded, final34,941, 10,753, 24,188R~work~/R~free~20.8/25.1No. of atoms Protein2,091 Waters131 Ligand/ions0RMSD Bond lengths (Å)0.011 Bond angles (°)1.317[^2][^3][^4]

Proline residues 987 and 1,071 at the center of β strands 1 and 4 and glycine 1,035 at the center of β strand 2 create a discontinuity which kinks of the β sheet, facilitating the curvature of the β taco ([Figure 2](#fig2){ref-type="fig"}E). The two molecules of TamB~963-1138~ are structurally analogous with a Cα root-mean-square deviation of 0.71 Å. The differences between the molecules is accounted for by flexible loops connecting the β strands; specifically, a large difference in conformation in the loop connecting β strands 6 and 7 ([Figure 2](#fig2){ref-type="fig"}F). As TamB~963-1138~ only represents a fragment of the larger TamB, the head-to-head dimer observed in the crystals structure is unlikely to be physiological. However, the oligomeric state of TamB *in vivo* has yet to been definitively determined, so the relevance of this dimer in unknown. The region of TamB N-terminal to TamB~963-1138~ is predicted to consist of a β structure, and so the interaction between the N-terminal strands of the two monomers may act as a surrogate for the β strands of full-length TamB ([Figure S3](#mmc1){ref-type="supplementary-material"}).

The Interior of the TamB~963-1138~ β taco Is Highly Hydrophobic {#sec2.2}
---------------------------------------------------------------

The most striking feature of the TamB~963-1138~ crystal structure is that the interior surface of its β taco is populated entirely by aliphatic and aromatic residues, making this interior cavity highly hydrophobic ([Figures 3](#fig3){ref-type="fig"}A and 3B). During purification of TamB~963-1138~ it was found that the detergent lauryldimethylamine N-oxide (LDAO) was required for stabilization of the domain. Purification of TamB~963-1138~ in the absence of LDAO led the protein to precipitate and resulted in a poor yield of purified protein. TamB~963-1138~ could be purified in the presence of LDAO and, once purified, the protein could be maintained in the absence of the detergent. However, while analytical SEC suggests that TamB~963-1138~ still exists as a dimer under these conditions ([Figure S2](#mmc1){ref-type="supplementary-material"}B), circular dichroism revealed it to be unstructured under these conditions, lacking the characteristic minima for β structured proteins ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Electron density possibly attributable to the aliphatic chains of stabilizing LDAO molecules is evident inside the TamB~963-1138~ cavity ([Figure 3](#fig3){ref-type="fig"}C). This density however, is insufficiently resolved to permit accurate modeling of the LDAO head groups and as a result it was not possible to unambiguously attribute it to the detergent. As such, LDAO was not included in the final model submitted to the PDB.Figure 3The Interior of the TamB~963-1138~ β Taco Is Hydrophobic(A) Cross-eye stereo view of TamB~**963-1138**~ showing as sticks the sidechains facing the interior of the β taco, all sidechains are hydrophobic.(B) Electrostatic surface model of TamB~963-1138~ molecules A and B, showing the hydrophobic groove.(C) Electron density present in the TamB~963-1138~ hydrophobic groove attributable to LDAO present in the crystallization buffer. The map presented in a feature-enhanced map generated using the Phenix package, contoured to 1.5 σ ([@bib2]).(D) An amphipathic β strand docked into the TamB~963-1138~ hydrophobic groove.

Given the periplasm-spanning topology of TamB, as well as the amphipathic characteristics in the substrate proteins assembled by the TAM, the hydrophobic β taco of TamB~963-1138~ structure is suggestive of a role for TamB in chaperoning membrane proteins across the periplasm to TamA in the OM. The open hydrophobic cleft of TamB~963-1138~ could shield the hydrophobic face of the β strand of an integral membrane protein, while leaving the hydrophilic face exposed to the aqueous environment. In support of this hypothesis, the interior of the TamB~963-1138~ β taco is of a width and depth sufficient to accommodate a single extended β strand ([Figure 3](#fig3){ref-type="fig"}D).

To test this hypothesis, we introduced the charged amino acids glutamate or arginine into full-length TamB in the place of Leu~1049~ and Ile~1102~, respectively. Both these amino acids reside in the TamB~963-1138~ hydrophobic β taco ([Figures 4](#fig4){ref-type="fig"}A and 4B). We then tested the ability of these mutant versions of TamB to complement a *ΔtamB E. coli* strain, by observing its function in an established pulse-chase assay, where TAM function is the rate-limiting step in the assembly the fimbrial usher protein FimD ([@bib32]). In this assay, proteinase K shaving of the bacterial cell surface is used to detect properly folded, radiolabeled FimD assembled in the OM. Exogenously added proteinase K cleaves FimD (90 kDa) at an extracellular loop, generating a C-terminal (40 kDa) and N-terminal (50 kDa) fragment. However, in the absence of the TAM, a 45 kDa "B fragment" is generated representing a central portion of FimD in a non-native conformation ([@bib32]).Figure 4The Effect on the Function of TamB of the Introduction of Charged Residues into the Hydrophobic β Taco of TamB~963-1138~(A) Positions of substitution of hydrophobic residues in the TamB~963-1138~ β taco (shown as red sticks). Glycine at position 1,073 is conserved with SSG4.(B) The local environment of the hydrophobic amino acid changed (panel 1) and their corresponding charged residue substitutions (panel 2).(C and D) The effect of the mutations shown in (A and B) on the ability of a plasmid-encoded copy of the *tamB* allele to complement a Δ*tamB* null-phenotype.(C) Pulse-chase assessment of ^35^S-FimD assembly was monitored over time in wild-type, Δ*tamA*, or Δ*tamB* cells. Each strain carried pKS02 (for *fimD* expression) and either the control pACYCDuet-1 plasmid, or the indicated complementing *tamB* plasmid. Aliquots were taken at the indicated timepoints and treated with or without 50 μg/mL proteinase K (PK). Total protein was analyzed by SDS-PAGE and storage phosphor imaging. The presence of the 45 kDa fragment B (labeled in red), is indicative of improperly folded FimD due to impaired functioning of the TAM. The defect observed in the complementation of *ΔtamB* with pTamB-I~1102~R is highlighted with a dashed rectangle.(D) Membrane extract of wild-type, Δ*tamA*, or Δ*tamB* cells harboring either the control pACYCDuet-1 plasmid, or the indicated complementing *tamB* plasmid, were prepared. Membrane protein (100 μg) was analyzed by blue native (BN)-PAGE and immunoblotting, using an antibody raised to the N-terminal POTRA domains of TamA ([@bib24]). The TAM does not form in Δ*tamA* or Δ*tamB* mutants. All alleles of *tamB* restore a wild-type phenotype to the TAM behavior on BN-PAGE.

Interestingly, placement of an Arg at position 1,102 (Ile~1102~Arg) significantly impaired the assembly of FimD, leading to the accumulation of the 45 kDa B fragment, indicating that the Ile~1102~Arg mutant can only partly complement a *tamB* null-phenotype ([Figure 4](#fig4){ref-type="fig"}C). Other mutations in the groove had less impact: the ability of the Leu~1049~Glu mutant to assemble FimD was indistinguishable from wild-type, BN-PAGE analysis of crude membrane extracts revealed that both mutant versions of TamB were capable of interacting with TamA to form the TAM, indicating that the defect in TamB^Ile1102Arg^ is not due to a gross defect in TamB production or structure ([Figure 4](#fig4){ref-type="fig"}D). Why TamB^Ile1102Arg^ was defective in our assay, but TamB^Leu1049Glu^ remained functional, is unknown. However, while the Leu~1049~Glu mutation would certainly change the local charge of the β taco, it does not project into the cavity to the extent that bulky arginine at 1,102 does. Future work involving more thorough mutagenesis studies of TamB would be useful in answering these questions.

To create the hydrophobic β taco structure found in TamB~963-1138~, the amino acid sequence of the β strands consist of alternating hydrophobic and hydrophilic amino acids. The sidechains projecting from a face of a β sheet are on alternate sides of the strands, so that the patterning observed in β taco of TamB creates one hydrophobic face (the internal cavity) and one hydrophilic face that would face the periplasmic environment. This sequence pattern is reminiscent of β barrel membrane proteins but in that case the hydrophobic side of the β sheet is embedded in the lipid bilayer. Sequence analysis of the TamB family reveals this alternating pattern of conserved hydrophobic and hydrophilic residues occurs not only in the TamB~963-1138~, but is widely distributed throughout the majority of TamB ([Figure S4](#mmc1){ref-type="supplementary-material"}). Extrapolating from the structure of TamB~963-1138~, this pattern suggests that the extended TamB molecule consists of long sections of hydrophobic channel. This proposed structure for TamB has a striking similarity to the well-characterized LPS transport system of Gram-negative bacteria ([@bib29]). Three proteins from this system, LptC, LptA, and LptD, contain or consist of a β jelly roll with an interior hydrophobic groove ([@bib6]). These proteins are predicted to interact to form a hydrophobic conduit for the aliphatic chains of LPS across the periplasm, from the inner to OMs ([@bib4], [@bib6]). In an interesting parallel to TamB~963-1138~, the β jelly domain of LptD, the OM component of this system, was crystallized with two detergent molecules in its hydrophobic groove ([@bib22]).

A Structure-Function Relationship in Distant DUF490 Homologs? {#sec2.3}
-------------------------------------------------------------

TamB homologs have been shown to be widely conserved in bacterial diderms, where they are involved in OM biogenesis in distantly related genera, from *Escherichia* to *Borrelia* to *Deinococcus* ([@bib12], [@bib15], [@bib25], [@bib38]). The distribution of TamB-like proteins is, however, not limited to the bacterial kingdom, with proteins containing the conserved DUF490 domain having also been identified in plants ([@bib12]). In a recent study screening rice (*Oryza sativa*) mutants for defects in starch accumulation, the protein SSG4 (for substandard starch grain 4) was identified. SSG4 is a large (2,132 amino acid) protein consisting of predominantly β structure and a TamB-like C-terminal DUF490 domain. SSG4 is localized to the amyloplast, the plastid responsible for starch synthesis in plants. This organelle was derived by evolution from an ancient symbiotic Cyanobacterium ([@bib5]). Mutation of Gly~1924~Ser in the DUF490 domain of SSG4 leads to enlarged starch granules and seed chalkiness ([@bib18]). The authors suggest that this glycine is crucial to function and that it is conserved in TamB proteins from Proteobacteria ([@bib18]). While plastids and Cyanobacteria share an evolutionary history, their protein-transport pathways are not homologous: proteins are imported into plastids from the cytoplasm, and there is no evidence of a vestigial protein secretion pathway from the internal compartments of the plastid out to its OM ([@bib14], [@bib30]). Therefore, if SSG4 also plays a role in membrane protein biogenesis in the plastid it must be distinct from that of TamB.

Sequence alignment between TamB and SSG4 shows that the conserved glycine falls within the TamB~963-1138~ crystal structure corresponding to Gly~1073~ ([@bib18]). Gly~1073~ is located in β strand 4, adjacent to the kink in the β sheet caused by Pro~1071~ ([Figure 4](#fig4){ref-type="fig"}A). To test the significance of glycine at this position for the function of TamB, we subjected it to mutagenesis. However, substitution of either serine or glutamate for Gly~1073~ did not affect the function of the TAM in the assembly of FimD into the OM of *E. coli* ([Figures 4](#fig4){ref-type="fig"}C and 4D). While this finding does not rule out the importance of Gly~1073~ in the function of TamB, it shows that substitution of this residue does not result in a gross defect in the function of this protein. To determine if TamB and SSG4 do indeed share a related function in these distantly related organisms, further investigation will be required.

STAR★Methods {#sec3}
============

Key Resources Table {#sec3.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-TamA (POTRA domains only) antibody produced in rabbitThis paperN.AAnti-Rabbit IgG (whole molecule)-Peroxidase antibody produced in goatSigma-AldrichA6154; RRID: [AB_258284](nif-antibody:AB_258284){#intref0010}**Bacterial and Virus Strains**E. coli DH5α: F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ-InvitrogenFor example: Cat\#, 18265017E. coli BL21(DE3): F- ompT hsdSB (rB-mB-) gal dcm (DE3)New England BiolabsFor example: Cat\#, C2527HE. coli BL21 Star™ (DE3): F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3)InvitrogenFor example: Cat\#, C6010-03E. coli BL21 Star™ (DE3) ΔtamA: F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) ΔtamA::Kan[@bib32]N.AE. coli BL21 Star™ (DE3) ΔtamB::Kan[@bib32]N.A**Chemicals, Peptides, and Recombinant Proteins**20 mg.mL-1 proteinase K solutionPromegaCat\#, MC500EXPRE35S35S \[35S\]-Protein Labelling MixPerkin ElmerNEG072Amersham ECL Prime Western Blotting Detection ReagentGE Healthcare Life SciencesRPN2232Dnase ASigmaCat\#, E1014EDTA-free Complete Protease Inhibitor CocktailRocheCat\#, 04693132001Ni-NTA AgaroseInvitrogenCat\#, R901-01LDAOSigmaCat\#, 40236**Deposited Data**Crystal Structure of TamB963-1138This paperPDB:[5VTG](pdb:5VTG){#intref0015}**Oligonucleotides**TamB Leu 1049 to Glu (TTTGGCCTGAAAGCGCGGGAGACGGGCGATCT\
CAATGT),This paperN.ATamB Gly 1073 to Ser (GCAGATCAACATCCCTGAAAGTCGCTTCCATGC\
CTATGGTC)This paperN.ATamB Gly 1073 to Glu (CAGATCAACATCCCTGAAGAGCGCTTCCATGCC\
TATGGTC)This paperN.ATamB Ile 1102 to Arg (GCCAGATCAACCGTATCTTAATCGTGAAGCTATTC\
GTAACCCGGA)This paperN.A**Recombinant DNA**pET21a, confers ampicillin resistanceMerck69740-3pACYCDuet-1, confers chloramphenicol resistance (used as an empty vector control for the various tamB complementation plasmids)NovagenCat\#, 71147-3pTamB, confers chloramphenicol resistance[@bib32]referred to as pCJS72 thereinpTamB-G1073S, confers chloramphenicol resistanceThis paperN.ApTamB-G1073E, confers chloramphenicol resistanceThis paperN.ApTamB-I1102R, confers chloramphenicol resistanceThis paperN.ApTamB-L1049E, confers chloramphenicol resistanceThis paperN.ApKS02, confers ampicillin resistance[@bib32]N.A**Software and Algorithms**Coot[@bib8]<https://sbgrid.org/software/>CCP4 suite[@bib36]<https://sbgrid.org/software/>XDS[@bib17]<https://sbgrid.org/software/>Phenix[@bib1]<https://sbgrid.org/software/>**Other**Storage phosphor screen: Unmounted General Purpose, 20 × 25 cmGE Healthcare Life SciencesCat\# 63-0034-87Exposure cassette for unmounted screens, 20 × 25 cmGE Healthcare Life SciencesCat\# 63-0035-44Typhoon TrioGE Healthcare Life Sciences63-0055-87SG50 gradient makerGE Healthcare Life SciencesSG50

Contact for Reagent and Resource Sharing {#sec3.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Rhys Grinter (<Rhys.grinter@monash.edu>).

Experimental Model and Subject Details {#sec3.3}
--------------------------------------

Expression of proteins used for crystallographic studies and analytical size exclusion chromatography (SEC) was performed in *E. coli* BL21(DE3). Cells were grown at 37°C in Terrific broth (TB). When optical density at 600 nm reached 0.8, protein expression was induced with the addition of 0.5 mM IPTG and cells were incubated overnight at 25°C before harvest.

For membrane isolation, BN-PAGE and pulse chase analyses, *E. coli* BL21 Star™ (DE3) and derivative strains were used. For plasmid storage, *E. coli* DH5α was used. These strains were routinely grown in lysogeny broth (LB, containing 10 g.L^-1^ tryptone, 5 g.L^-1^ yeast extract and 5 g.L^-1^ NaCl), at 37°C and 200 strokes per minute (25 mm orbit). For strain storage, saturated overnight culture was diluted 1:1 in 40 % v/v glycerol, snap frozen in liquid nitrogen and kept at -80°C.

Where appropriate, the following antibiotics were used for selection: 34 μg.mL^-1^ chloramphenicol, 30 μg.mL^-1^ kanamycin, and/or 100 μg.mL^-1^ ampicillin. If solid media was required, 15 g.L^-1^ agar was added to the growth medium.

Method Details {#sec3.4}
--------------

### Protein Expression, Purification, Crystallization and Data Collection {#sec3.4.1}

Native TamB~963-1138~ was expressed and purified as described by ([@bib16]). Briefly, the gene fragment encoding the DUF490 domain residues 963-1138 from TamB from *E. coli* K12 was ligated into pET-21a via NdeI and XhoI restriction sites producing a C-terminally His~6~ tagged product. This construct was transformed into *E. coli* BL21 (DE3) cells which were grown in LB (+ 100 ug.ml^-1^ Ampicillin and 3% glycerol) to an OD of 0.6, before induction with 0.5 mM IPTG. Cells were then grown for 15 hours at 25°C and harvested by centrifugation (5000 g). Cells were resuspended in 20 mM Tris--HCl, 10 mM imidazole, 0.5 M NaCl, 5%(v/v) glycerol, 0.05% LDAO pH 7.5 then lysed via sonication, supernatant was clarified by centrifugation (30,000 g). TamB~963-1138~ was purified from this clarified supernatant by a 2-step purification of nickel affinity and size exclusion (Superdex S200) chromatography. Clarified cell lysate was applied to a 5ml Ni-agarose column and the column was washed with at least 10 column volumes of 20 mM Tris--HCl, 10 mM imidazole, 0.5 M NaCl, 5%(v/v) glycerol, 0.05% LDAO pH 7.5. Protein was then eluted from the column with a 0-100% gradient of of 20 mM Tris--HCl, 500 mM imidazole, 0.5 M NaCl, 5%(v/v) glycerol, 0.05% LDAO pH 7.5 over 10 column volumes. Fractions containing DUF490~963-1138~ were then applied to a 26/200 Superdex S200 column equilibrate in 20 mM Tris-HCl, 200 mM NaCl, 0.05% LDAO. DUF490~963-1138~ eluted as multimeric species on size exclusion, however a single peak most likely corresponding to a monomer or dimer was pooled and concentrated to 8-15 mg.ml^-1^ prior sparse matrix screening for crystallization conditions.

For selenomethionine labelling TamB~963-1138~ expression construct described above was transformed into the methionine auxotrophic strain *E. coli* B834 (DE3). Cells were grown at 37°C in M9 minimal media (+ 100 ug.ml^-1^ ampicillin, 50 ug.ml^-1^ selenomethionine, 100 ug.ml^-1^ other amino acids, 0.5 ug.ml thiamine) to an OD~600~ of 0.4 before induction with 0.5 mM IPTG. Cells were then grown for 15 hours at 25°C before harvesting, and protein purified as described above. 1 mM DTT was included in all buffers to prevent oxidation of the selenium.

Crystallisation was performed as previously described ([@bib16]). Protein for crystalisation was in a buffer containing: 50 mM Tris--HCl, 200 mM NaCl, 0.05% LDAO pH 7.5. Crystals were grown with a reservoir solution containing: 0.1 M HEPES, 15%(v/v) PEG 400, 0.2 M CaCl2 pH 7.0. Crystals were transferred to cryoprotectant consisting of reservoir solution with 25%(v/v) PEG 400 and flash cooled in liquid nitrogen. Data was collected at 100°K (0.9752 Å) at Diamond Lightsource, UK.

### Size-Exclusion Chromatography Multiangle Light Scattering (SEC-MALS) {#sec3.4.2}

The absolute molecular mass of TamB~963-1138~ was determined by SEC-MALS. 100-μl protein samples (1-5 mg.ml^-1^) were loaded onto a Superdex 200 10/300 GL size-exclusion chromatography column in 20 mM Tris, 200 mM NaCl 0.05 % LDAO \[pH 7.9\] at 0.6 ml/min with a Shimadzu Nexera SR. The column output was fed into a DAWN HELEOS II MALS detector (Wyatt Technology) followed by an Optilab T-rEX differential refractometer (Wyatt Technology). Light scattering and differential refractive index data were collected and analyzed with ASTRA 6 software (Wyatt Technology). Molecular masses and estimated errors were calculated across individual eluted peaks by extrapolation from Zimm plots with a dn/dc value of 0.1850 ml/g. SEC-MALS data are presented with light scattering (LS) and refractive index change plotted alongside fitted molecular masses (Mr).

### Circular Dichroism Analysis {#sec3.4.3}

Circular dichorism measurements were obtained for TamB~963-1138\ at~ 1 mg/ml in 20 mM Tris, 200 mM NaCl \[pH 7.9\] the presence and absence of 0.03 % LDAO at 24°C using a Jasco J-810 spectropolarimeter (Jasco UK Ltd).

### Experimental Phasing, Model Building and Refinement {#sec3.4.4}

Based on the Matthews coefficient for the DUF490~963-1138~ crystals, two molecules were predicted to be present in the crystal asymmetric unit (ASU), with a solvent content of 50 %. One molecule per ASU was also a possibility, with a solvent content of 76 %. Each DUF490~963-1138~ molecule has 2 methionine residues (discounting the N-terminal methionine which is likely to be cleaved), giving 4 as the most likely number selenium atoms present. To locate heavy atom sites in diffraction data from the selenomethionine labelled DUF490~963-1138~ data was collected at the selenium edge and processed to 2.7 Å. Anomalous signal for the data was detected up to 7.4 Å using Xtriage from the Phenix package ([@bib1]). This was weaker than expected given the methionine to amino acid residue ratio (1:88). ShelxC was employed for data preparation, followed by ShelxD to locate selenium sites ([@bib26]). The best substructure solutions were obtained with 3 selenium sites with occupancies of 0.87, 0.47 and 0.31, rather than the 4 sites expected for 2 molecules per ASU. These sites were then provided along with the DUF490 anomalous dataset to Autosol from the Phenix package for phasing and density modification ([@bib1]). Contrast of the initial experimentally phased maps was poor, making it difficult to determine the corrected hand of the screw axis (P3~1~21 or P3~2~21). However, density modification greatly improved map contrast with clear density present for molecules consisting of an elongated U-shaped β-sheet in the solution from the correct hand with the space group P3~2~21 ([Figure S1](#mmc1){ref-type="supplementary-material"}). This experimentally phased map was then used to construct a provisional model. This structure was then used as a molecular replacement model for the higher resolution native data (2.1 Å). The DUF490~963-1138~ was then iteratively built and refined using COOT and Phenix refine to give the final structure with R~work~ and R~free~ of 20.8% a 25.1% respectively ([@bib8]).

### Sequence and Structure Analysis {#sec3.4.5}

Structural analysis and figure construction was performed using pymol and QtMG structural graphics packages ([@bib19]). Secondary structure prediction for TamB was performed using the JPred4 webserver ([@bib7]).

Amino acid sequences for TamB homologues were identified using a Hmmer search against the rp15 database, with TamB from *E. coli* as the query sequence and an e-value cut off of 1e-30. Sequences identified were triaged for those +/- 500 amino acids in length of TamB *from E. coli* and aligned using clustalx ([@bib9]).

### TamB Plasmid Mutagenesis {#sec3.4.6}

In order to introduce single amino acid mutations onto the TamB~963-1138~ region of *tamB* in pTamB (pCJS72) the whole plasmid PCR mutagenesis method was utilised. A reaction was assembled in 50 μl H~2~O containing: 2.5 U (1 μl) PfuTurbo polymerase, 5 μl 10 x Pfu reaction buffer, 125 ng each of forward and reverse primers (see below), 50 ng pTamB DNA and 1 μl 10 mM dNTP mix. The following forward primers were utilised for each mutation, with the reverse complement of the listed sequence used for the reverse primer:

Leu 1049 to Glu (TTTGGCCTGAAAGCGCGGGAGACGGGCGATCTCAATGT),

Gly 1073 to Ser (GCAGATCAACATCCCTGAAAGTCGCTTCCATGCCTATGGTC),

Gly 1073 to Glu (CAGATCAACATCCCTGAAGAGCGCTTCCATGCCTATGGTC),

Ile 1102 to Arg (GCCAGATCAACCGTATCTTAATCGTGAAGCTATTCGTAACCCGGA)

The reaction mixture was subjected to the following thermocycling regime: 1 x 95°C for 30 seconds, 18 x ( 95°C for 30 seconds, 55°C for 60 seconds, 68°C for 7 minutes). 1 μl of DpnI was then added to the reaction which was incubated at 37°C for 1 hour. The reaction mixture was then transformed into *E. coli* DH5α and plated onto LB agar containing 30 μg/ml chloramphenicol. Plasmid DNA was extracted from resultant colonies and sequenced to confirm that the desired mutation and no other mutations were present.

### Chemical Transformation {#sec3.4.7}

*E. coli* DH5α were Saturated overnight cultures were diluted 1:50 into fresh 30 mL LB, supplemented with appropriate antibiotics, and incubated until mid-log phase. The culture was chilled on ice for 30 min, then subjected to centrifugation (4415 ×g, 4°C, 15 min) and resuspended in 4.5 mL ice cold 0.1 M CaCl~2~. The suspension was chilled on ice for a further 30 min, centrifuged as before and resuspended in 150 μL 0.1 M CaCl~2~. Following a 2-hour incubation on ice, 75 μL LB (supplemented with 30 % w/v glycerol) were aliquoted and snap frozen and stored at -80°C.

Cells (20-50 μL) were thawed on ice and incubated with 20-50 ng plasmid DNA for 40 min on ice. Cells were heat shocked at 42°C for 45 s, then incubated on ice for 2 min before 250 μL LB media was added and cells were allowed to recover for 1 hour. Samples were then spread-plated onto LB agar containing appropriate antibiotics, and following a 24-hour incubation at 37°C, transformants were selected for subsequent analyses.

### Electro-Transformation {#sec3.4.8}

Saturated overnight cultures were diluted 1:50 into fresh 30 mL LB, supplemented with appropriate antibiotics, and incubated until mid-log phase. The culture was subjected to four rounds of centrifugation (3485 ×g, 4°C, 10 min), followed by resuspension in increasingly smaller volumes of 10% v/v glycerol: 12 mL, 6 mL, 3 mL, 0.3 mL. Cells (50 μL) were briefly incubated on ice with 20-50 ng plasmid DNA and then transferred to a chilled electroporation cuvette (1 mm gap). Samples were electroporated (1.8 kV, 200 Ω, 25 μF) and immediately transferred to 250 μL LB and allowed to recover for 1 hour. Transformants were then selected for on solid media, supplemented with appropriate antibiotics, after a 24-hour incubation at 37°C.

### Crude Membrane Isolation {#sec3.4.9}

Saturated overnight cultures were diluted 1:100 into fresh 50 mL LB, supplemented with appropriate antibiotics, and incubated until the optical density at 600 nm was between 0.8 and 1.2. The culture was subjected to centrifugation (4609 ×g, 4°C, 10 min) and then resuspended in 10 mL sonication buffer (2 mM EDTA, 150 mM NaCl, 10 mM Tris-HCl, pH 7.5). Samples were lysed by sonication and the sample was subjected to centrifugation to remove unbroken cells (2668 ×g, 4°C, 5 min). The supernatant was then subjected to centrifugation (16743 ×g, 4°C, 10 min), and the membrane pellet was resuspended in 1 mL SEM buffer (1 mM EDTA, 250 mM sucrose, 10 mM MOPS-KOH, pH 7.2). Membranes were snap frozen in liquid nitrogen, and stored at -80°C.

### Blue Native-PAGE and Immunoblotting {#sec3.4.10}

Membranes comprising 150 μg.μL^-1^ protein were thawed on ice, and subjected to centrifugation (13600 ×g, 4°C, 5 min). Membranes were resuspended in 36 μL blue native lysis buffer (10 mg.mL^-1^ DDM, 1 mM PMSF, 50 mM NaCl, 50 mM 6-aminohexanoic acid, 1 mM EDTA, 7.5 % w/v glycerol, 25 mM imidazole-HCl, pH 7.0) (Note: PMSF has a short half-life in aqueous solutions and was therefore added immediately before use from a master stock of 100 mM PMSF in isopropanol). Samples were incubated on ice for no more than 30 min, and then subjected to centrifugation (21200 ×g, 4°C, 10 min). The supernatant was transferred to 9 μL 5× blue native sample buffer (3 parts blue native lysis buffer and 1 part of a stock solution comprising 100 mM 6-aminohexanoic acid and 4 % w/v coomassie brilliant blue G-250). With a 40 % T, 2.6 % C acrylamide/bis acrylamide solution (such as 40% Acrylamide/bis solution 37.5:1, Bio-Rad, cat\#1610148), a 4 % acrylamide (4 % v/v acrylamide 37.5:1 mixture, 3.75 % w/v glycerol, 500 mM 6-aminohexanoic acid, 25 mM imidazole-HCl, pH 7.0, 0.1 % v/v TEMED, 0.09 % w/v ammonium persulfate) and a 14 % acrylamide (14 % v/v acrylamide 37.5:1 mixture, 20.25 % w/v glycerol, 500 mM 6-aminohexanoic acid, 25 mM imidazole-HCl, pH 7.0, 0.05 % v/v TEMED, 0.045% w/v ammonium persulfate) mixture were used to cast a 4-14 % blue native gradient gel with an SG50 gradient maker as per manufacturer's instructions.

Samples (30 μL, comprising 100 μg membrane protein) and size markers (30 μL, 1.5 μg.μL^-1^ ferritin, 1.5 μg.μL^-1^ catalase, 1.5 μg.μL^-1^ BSA, 50 mM NaCl, 55 mM 6-aminohexanoic acid, 1 mM EDTA, 7.5 % w/v glycerol, 0.2 % w/v Coomassie brilliant blue G-250, 25 mM imidazole-HCl, pH 7.0) were loaded onto 4-14 % blue native gradient gels and analysed by blue native PAGE as follows. Anode buffer (25 mM imidazole-HCl, pH 7.0) and dark blue cathode buffer (0.05 % w/v Coomassie brilliant blue G-250, 50 mM tricine-imidazole, pH 7.0) were added to the lower and upper tanks, respectively, and subjected to electrophoresis (250 V, 7.5-8.0 mA, 4°C), until the dye front has migrated two-thirds of the gel. Replace the buffer in the upper tank with a slightly blue cathode buffer (0.001 % w/v Coomassie brilliant blue G-250, 50 mM tricine-imidazole, pH 7.0) and subject to electrophoresis (250 V, 7.5-8.0 mA, 4°C) until the dark blue cathode buffer within the gel has been completely replaced by the slightly blue cathode buffer. Samples in the gel were denatured as follows. Blue native denaturing buffer (1 % w/v DTT, 4 % w/v SDS, 50 mM Tris-HCl, pH 6.8) was heated to 65°C and poured over the 4-14 % blue native gradient gel (100 mL per 15 × 7 cm gel). The gel was then incubated (37°C, 40 rpm, 25 mm orbit) for 20 min, and after briefly rinsing the gel in water, it was transferred to CAPS western transfer buffer (10 % v/v methanol, 20 mM CAPS-NaOH, pH 11.0) and incubated (room temperature, 40 rpm, 25 mm orbit) for 10 min. Denatured protein was transferred to 0.45 μm PVDF membranes (as per manufacturer's instructions) using CAPS western transfer buffer.

Residual coomassie was removed from the PVDF membrane (with methanol), before rinsing briefly in TBS-T buffer (0.2 % v/v Tween-20, 8 g.L^-1^ NaCl, 0.2 g.L^-1^ KCl, 30 g.L^-1^ Tris-HCl, pH 7.4). Membranes were incubated in blocking buffer (2.5 % w/v skim milk powder in TBS-T) for 30-60 min (room temperature, 40 rpm, 25 mm orbit) or overnight (4°C, 40 rpm, 25 mm orbit), before incubation in rabbit anti-TamA antibodies (1:20,000 dilution in blocking buffer) for 1 hour (room temperature, 40 rpm, 25 mm orbit). Membranes were washed three times in TBS-T (room temperature, 40 rpm, 25 mm orbit) for 5-10 min each, before incubation in goat anti-rabbit antibodies (1:20,000 dilution in blocking buffer) for 30 min (room temperature, 40 rpm, 25 mm orbit). Membranes were then washed as before, followed by incubation with Amersham ECL Prime Western Blotting Detection Reagent as per manufacturer's instructions. Chemiluminescent membranes were then exposed to super RX-N film (Fujifilm) in an Amersham Hypercassette™ (GE Healthcare Life Sciences) for up to 10 min, and developed using the SRX-101A medical film processor (Konica) as per manufacturer's instructions.

### Pulse Chase Analysis of FimD Assembly {#sec3.4.11}

Saturated overnight cultures were diluted 1:100 into fresh LB, supplemented with chloramphenicol and ampicillin, and incubated until mid-log phase. The culture was subjected to centrifugation (4609 ×g, 4°C, 10 min), washed in M9-S media (47.8 mM Na~2~HPO~4~, 22 mM KH~2~PO~4~, 8.56 mM NaCl, 11.1 mM glucose, 1.12 mM thiamine, 1 mM MgCl~2~, 0.1 mM CaCl~2~ and 45.4 pg.mL^-1^ of the 18 standard non-sulphur containing amino acids, with an additional 181.6 pg.mL^-1^ leucine \[i.e. 227 pg.mL^-1^ leucine total\]), and after another round of centrifugation, was resuspended in M9-S media (equal to the volume of LB removed following centrifugation). After 30 min incubation (37°C, 200 rpm, 25 mm orbit), cells were normalised to an optical density at 600 nm of 0.6 and diluted 1:1 in 40 % v/v glycerol. The samples were then snap-frozen (1.3 mL aliquots) in liquid nitrogen and stored at -80°C. Each batch of cells was considered to be one set of technical replicates.

Aliquots were thawed on ice, subjected to centrifugation (3000 ×g, 4°C, 5 min) and resuspended in 650 μL M9-S media. Rifampicin (500 μg mL^-1^) was added to inhibit transcription (37°C, 400 rpm, 3 mm orbit) for 60 min before 0.2 mM of pre-warmed IPTG was added (30°C, static) to induce pKS02-based *fimD* expression for 5 min. Cells were then 'pulsed' with 22 μCi.mL^-1^ of pre-warmed EXPRE^35^S^35^S \[^35^S\]-Protein Labelling Mix (routinely containing 73 % \[^35^S\]-methionine, 22 % \[^35^S\]-cysteine) for 45 s, then immediately transferred to ice. Samples were then subjected to centrifugation (3000 ×g, 4°C, 5 min) and resuspended in 650 μL M9+S media (M9-S media, but 1 mM MgSO~4~ replaces MgCl~2~ and 45.5 pg.mL^-1^ methionine and cysteine were added). The 'chase' component was considered to have begun immediately on resuspension of M9+S media and was performed for 32 minutes (30°C, static).

For analysis by protease shaving, at each chase time point (10 sec, 2, 4, 8, 16, and 32 min), 50 μL aliquots were incubated on ice for 10 min with (all time points) or without (32 min timepoint only) 50 μg/mL proteinase K. Trichloroacetic acid (10 % v/v final) was then added and protein precipitates were collected by centrifugation (25000 ×g, 4°C, 15 min). The precipitate was washed with acetone, subjected to centrifugation as before, and the pellet was air-dried. The sample was resuspended in 50 μL SDS sample buffer (10 % v/v glycerol, 1 % w/v SDS, 100 mM DTT, 0.01 % w/v bromophenol blue, 100 mM Tris-HCl, pH 6.8) and boiled for 3-5 min. Samples (10 μL) were loaded into 12% SDS acrylamide gel and analysed by SDS-PAGE. Proteins were transferred to 0.45 μm nitrocellulose membrane and the membrane was air dried. Radiation was captured for 12-18 hours using the storage phosphor screen (as per manufacturer's instructions) and analysed using the Typhoon Trio (320 nm).

Quantification and Statistical Analysis {#sec3.5}
---------------------------------------

Statistical methods were not utilised in analysis of the significance of data in this study

Data and Software Availability {#sec3.6}
------------------------------

The coordinates and structure factors for the crystal structure of TamB~963-1138~ have been deposited in the PDB under the accession number: [5VTG](pdb:5VTG){#intref0045}

Author Contributions {#sec4}
====================

R.G., C.J.S., I.J., D.W., and K.M. conceived and designed the experiments; R.G., C.J.S., G.V., and I.J. performed the experiments; R.G., C.J.S., G.V., I.J., D.W., and K.M. analyzed the data; R.G., T.L., and D.W. contributed reagents/materials/analysis tools; R.G., C.J.S., T.L., I.J., and D.W. wrote the paper.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S4 and Table S1Document S2. Article plus Supplemental Information

We thank the Diamond Light Source for access to beamlines I02, I04-1, and I24 (proposal numbers MX6638 and MX8659). The work was funded by the NHMRC Program in Cellular Microbiology (1092262). R.G. was funded by a Sir Henry Wellcome Fellowship (award number 106077/Z/14/Z). During this work I.J. was supported by a studentship from the Wellcome Trust (award number 093592/Z/10/Z).

Supplemental Information includes four figures and one table and can be found with this article online at [https://doi.org/10.1016/j.str.2017.10.002](10.1016/j.str.2017.10.002){#intref0050}.

[^1]: Lead Contact

[^2]: Data from one crystal were collected for each structure. RMSD, root-mean-square deviation.

[^3]: Values in parentheses are for highest-resolution shell.

[^4]: Correction applied using the "Diffraction Anisotropy Server" ([@bib31]).
